Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Scheckenbach

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|November 15, 2005
T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynxThomas K Hoffmann, Christian Arsov, Kerstin Schirlau, et al.
The Annals of Otology, Rhinology, and Laryngology|August 27, 2015
Evaluation of Customized Prosthesis for Irregularly Formed Tracheostoma After LaryngectomyJohannes Doescher, Kathrin Scheckenbach, Wolfgang Angerstein, et al.
Anticancer Research|March 10, 2015
MicroRNA expression in differentially metastasizing tumors of the head and neck: adenoid cystic versus squamous cell carcinomaJohannes A Veit, Kathrin Scheckenbach, Patrick J Schuler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2021
DNA Methylation and mRNA Expression of OX40 (TNFRSF4) and GITR (TNFRSF18, AITR) in Head and Neck Squamous Cell Carcinoma Correlates With HPV Status, Mutational Load, an Interferon-γ Signature, Signatures of Immune Infiltrates, and SurvivalSophia M Loick, Anne Fröhlich, Jennis Gabrielpillai, et al.
Oral Oncology|April 25, 2021
CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cellsCorinna Haist, Elena Schulte, Nina Bartels, et al.
Frontiers in Immunology|December 6, 2021
Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-CellsCamilla M Grunewald, Corinna Haist, Carolin König, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 19, 2025
Prognostic gene expression signatures for HPV-negative head and neck squamous cell carcinomaStefano Cavalieri, Ruud H Brakenhoff, C René Leemans, et al.
Cell Reports|January 10, 2019
The Wnt-Driven Mll1 Epigenome Regulates Salivary Gland and Head and Neck CancerQionghua Zhu, Liang Fang, Julian Heuberger, et al.
Oral Oncology|July 26, 2021
The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysisIrene H Nauta, Thomas Klausch, Peter M van de Ven, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2023
Prognostic radiomic signature for head and neck cancer: Development and validation on a multi-centric MRI datasetMarco Bologna, Valentina Corino, Stefano Cavalieri, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|November 15, 2005
T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynxThomas K Hoffmann, Christian Arsov, Kerstin Schirlau, et al.
The Annals of Otology, Rhinology, and Laryngology|August 27, 2015
Evaluation of Customized Prosthesis for Irregularly Formed Tracheostoma After LaryngectomyJohannes Doescher, Kathrin Scheckenbach, Wolfgang Angerstein, et al.
Anticancer Research|March 10, 2015
MicroRNA expression in differentially metastasizing tumors of the head and neck: adenoid cystic versus squamous cell carcinomaJohannes A Veit, Kathrin Scheckenbach, Patrick J Schuler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2021
DNA Methylation and mRNA Expression of OX40 (TNFRSF4) and GITR (TNFRSF18, AITR) in Head and Neck Squamous Cell Carcinoma Correlates With HPV Status, Mutational Load, an Interferon-γ Signature, Signatures of Immune Infiltrates, and SurvivalSophia M Loick, Anne Fröhlich, Jennis Gabrielpillai, et al.
Oral Oncology|April 25, 2021
CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cellsCorinna Haist, Elena Schulte, Nina Bartels, et al.
Frontiers in Immunology|December 6, 2021
Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-CellsCamilla M Grunewald, Corinna Haist, Carolin König, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 19, 2025
Prognostic gene expression signatures for HPV-negative head and neck squamous cell carcinomaStefano Cavalieri, Ruud H Brakenhoff, C René Leemans, et al.
Cell Reports|January 10, 2019
The Wnt-Driven Mll1 Epigenome Regulates Salivary Gland and Head and Neck CancerQionghua Zhu, Liang Fang, Julian Heuberger, et al.
Oral Oncology|July 26, 2021
The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysisIrene H Nauta, Thomas Klausch, Peter M van de Ven, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2023
Prognostic radiomic signature for head and neck cancer: Development and validation on a multi-centric MRI datasetMarco Bologna, Valentina Corino, Stefano Cavalieri, et al.
Pageof 8